SUMMARY
The C 30 carotene synthase CrtM from Staphylococcus aureus and the C 40 carotene synthase CrtB from Erwinia uredovora were swapped into their respective foreign C 40 and C 30 biosynthetic pathways (heterologously expressed in Escherichia coli) and evaluated for function. Each displayed negligible ability to synthesize the natural carotenoid product of the other. After one round of mutagenesis and screening, we isolated 116 variants of CrtM able to synthesize C 40 carotenoids. In contrast, we failed to find a single variant of CrtB with detectable C 30 activity. Subsequent analysis revealed that the best CrtM mutants performed comparably to CrtB in an in vivo C 40 pathway and that Phe 26 of CrtM is a key specificity-determining residue. The CrtM mutants showed significant variation in performance in their original C 30 pathway, indicating the emergence of enzymes with broadened substrate specificity as well as those with shifted specificity. We also report for the first time the isolation of carotenoid pigments based on a C 35 carbon backbone formed by condensation of farnesyl diphosphate (FPP) and geranylgeranyl dipohosphate (GGPP) by wild-type and variants of CrtM. The expanded substrate and product range of the CrtM mutants reported herein highlights the potential for creating further new carotenoid backbone structures.
INTRODUCTION
A common feature of small molecule natural product biosynthetic pathways is the extensive use of enzymes with broad substrate and product specificities. Many isoprenoid biosynthetic enzymes, for example, accept a variety of both natural and unnatural substrates (27, 28, 31) . Some have been shown to synthesize an impressively large number of compounds (sometimes >50) from a single substrate (9, 12, 45) . Natural product biosynthetic pathways also use enzymes with remarkably stringent specificity.
Such enzymes are frequently seen in key determinant positions, usually in the very early steps of a pathway, while promiscuous enzymes tend to be located further downstream.
Thus, many natural product pathways have a "reverse tree" topology (3, 42) where the backbone structures of metabolites are dictated by a small number of stringent, upstream enzymes. When the substrate or product preferences of these key upstream enzymes are altered, pathway branches leading to sets of novel compounds may be opened (10) . Our interest is to achieve the same by applying methods of directed enzyme evolution to recombinant pathways in Escherichia coli (43, 50) .
Among the most widespread of all small molecule natural products, carotenoids are natural pigments that play important biological roles. Some are accessory lightharvesting components of photosynthetic systems, while others are photo-protecting antioxidants or regulators of membrane fluidity. Recent studies advocate their effectiveness in preventing cancer and heart disease (26) as well as their potential hormonal activity (4, 18) . Such diverse molecular functions justify exploring rare or novel carotenoid structures. At present, ~700 carotenoids from the naturally occurring C 30 and C 40 carotenoid biosynthetic pathways have been characterized (17) . Most natural carotenoid diversity arises from differences in types and levels of desaturation and other modifications of the C 40 backbone. C 40 carotenoids are also much more widespread in nature than their C 30 counterparts. The former are synthesized by thousands of plant and microbial species, whereas the latter are known only in a select few bacteria (46, 48) .
Homocarotenoids (carotenoids with >40 carbon atoms) and apocarotenoids (carotenoids with <40 carbon atoms), which result from the action of downstream enzymes on a C 40 substrate, are also known. Although these structures do not have 40 carbon atoms, they are nonetheless derived from C 40 carotenoid precursors (5).
The first committed step in carotenoid biosynthesis is the head-to-head condensation of two prenyl diphosphates catalyzed by a synthase enzyme (Figure 2.1 ).
The C 40 carotenoid phytoene is synthesized by the condensation of two molecules of geranylgeranyl diphosphate (GGPP, C 20 PP) catalyzed by the synthase CrtB. (Most phytoene synthases produce the 15Z isomer of phytoene (5)). C 30 carotenoids are synthesized via an independent route whereby two molecules of farnesyl diphosphate (FPP, C 15 PP) are condensed to (15Z)-4,4'-diapophytoene by CrtM (48) . The various downstream modification enzymes possess broad substrate specificity and therefore represent potential targets for generating biosynthetic routes to novel carotenoids. For example, when the three-step phytoene desaturase CrtI from Rhodobacter sphaeroides was replaced with a four-step enzyme from Erwinia herbicola, the cells accumulated a series of carotenoids produced neither by Erwinia nor Rhodobacter (16) . Carotene desaturases (39) , carotene cyclases (44) , and β,β-carotene cleavage enzyme (40) have also been shown to accept a broad range of substrates. Combinatorial expression of such enzymes can create unusual and sometimes previously unidentified carotenoids (1, 2, 21) . Nevertheless, the greatest potential to further extend carotenoid biosynthetic diversity lies in creating whole new backbone structures, and therefore with engineering the carotene synthases.
The C 30 and C 40 pathways are very similar except in the sizes of their precursor molecules and their distributions in nature, and it is clear that they diverged from a common ancestral pathway. We would like to determine the minimal genetic change required in key carotenoid biosynthetic enzymes to create such new pathway branches.
Can the enzymes that synthesize one carotenoid be modified in a laboratory evolution experiment to synthesize others? How much of carotenoid diversity can be accessed in this way? And, can novel pathways to different, even unnatural structures (e.g., C 35 , C 45 , C 50 , or larger carotenoids) be accessed by using C 30 or C 40 enzymes as a starting point?
To begin to answer these questions, we studied the performance of the C 30 carotene synthase CrtM from Staphylococcus aureus in a C 40 pathway and the C 40 carotene synthase CrtB from Erwinia uredovora in a C 30 pathway. We then examined the ability of these enzymes to adapt to their respective "foreign" pathways in order to assess the ease and uncover the mechanisms by which this might be accomplished.
RESULTS AND DISCUSSION

Constructing pathways for C 30 and C 40 carotenoids
To establish a recombinant C 40 pathway in E. coli, we subcloned crtE encoding GGPP (C 20 PP) synthase, crtB encoding phytoene synthase, and crtI encoding phytoene desaturase, all from E. uredovora, into a vector derived from pUC18, resulting in plasmid pUC-crtE-crtB-crtI (Figure 2.2a) (Figure 2.2a) . With this arrangement, corresponding genes could be easily swapped in order to evaluate their function in the other pathway.
E. coli cells harboring pUC-crtE-crtB-crtI plasmids (C 40 pathway) developed a characteristic red-pink color, whereas cells possessing pUC-fps-crtM-crtN and pUCcrtM-crtN plasmids (C 30 pathway) were yellow (Figure 2.2b) . HPLC analysis of extracted pigments showed that XL1-Blue(pUC-crtE-crtB-crtI) cells produce mostly lycopene (four-step desaturation) along with a small amount (5 to 10% of total pigment) of 3,4,3',4'-tetradehydrolycopene (six-step desaturation) under the conditions described.
Although CrtI is classified as a four-step desaturase, production of 3,4-didehydrolycopene (five-step desaturation) by CrtI both in vivo and in vitro has been reported (15, 23) .
Several groups have expressed CrtM and CrtN from S. aureus in E. coli and observed almost exclusive production of 4,4'-diaponeurosporene (39, 51) . However, in our XL1-Blue(pUC-crtM-crtN) expression system, the cells accumulated a significant amount of 4,4'-diapolycopene (~30% of total carotenoids). When a constitutive lac promoter (lacking the operator) was used for operon expression, the amount of 4,4'-diapolycopene increased further and reached 50% of carotenoids produced (D. Umeno, unpublished data). This phenomenon was observed in all E. coli strains we tested, BL21, BL21(DE3), JM109, JM101, DH5α, HB101, SCS110, and XL10-Gold, and was insensitive to growth temperature and plasmid copy number. Thus, it is clear that the apparent desaturation step number of CrtN depends on its expression level and the effective concentration of substrates. 
Screening for synthase function in a foreign pathway
In the previous section, we confirmed that the carotene synthases CrtB and CrtM show negligible activity in their respective foreign pathways. We next proceeded to evolve the two enzymes, with the goal of improving the function of each in the other's native pathway. To uncover CrtB variants with significant CrtM-like ability to synthesize Mutations found in these variants (Table 2.1) were heavily biased toward transitions: 36 versus only 3 transversions. Additionally, 87% of the base substitutions found by sequencing were A/T→G/C. This is a typical observation for PCR mutagenesis with MnCl 2 (7, 24) . Out of 39 total nucleotide substitutions, 24 resulted in amino acid substitutions. Most notably, 9 of the 10 sequenced CrtM mutants had a mutation at phenylalanine 26.
Carotenoid production of evolved CrtM variants
We analyzed in detail the in vivo carotenoid production of variant M 8 , which has the F26L mutation only; variant M 9 , which has the F26S mutation; and variant M 10 , which has no mutation at F26. To confirm the newly acquired CrtB-like function of these three sequenced variants of CrtM, XL1-Blue cultures carrying each of the three plasmids pUC-crtE-M 8 -crtI, pUC-crtE-M 9 -crtI, and pUC-crtE-M 10 -crtI (collectively referred to as pUC-crtE-M 8-10 -crtI) were cultivated in TB medium. Extracted pigments were analyzed by HPLC with a photodiode array detector (Figure 2.4) . These analyses revealed that all three clones produced the C 40 carotenoids lycopene (peak 5) and 3,4,3',4'-tetradehydrolycopene (peak 4) as major products, whereas cells harboring the parent pUC-crtE-crtM-crtI plasmid produced mainly C 30 and trace amounts of C 40 and C 35 carotenoids. Two carotenoids with C 35 backbone structures were detected in extracts from cells harboring pUC-crtE-crtM-crtI and pUC-crtE-M 8-10 -crtI. Elution profiles, UV-visible spectra, and mass spectra confirm that one of the structures is the fully conjugated C 35 carotenoid 4-apo-3',4'-didehydrolycopene. We also detected C 35 
Direct product distribution of CrtM variants in the presence of GGPP (C 20 PP)
To directly evaluate the product specificities of the three CrtM mutants, we constructed pUC-crtE-M 8-10 plasmids and transformed the plasmids into XL1-Blue cells.
Here the CrtM variants are supplied with GGPP, but the carotenoid products cannot be desaturated. Because all three possible products in this scenario, 4,4'-diapophytoene (C 30 ), 4-apophytoene (C 35 ), and phytoene (C 40 ), have an identical chromophore structure consisting of three conjugated double bonds, the molecular extinction coefficients for all three can be assumed to be equivalent, irrespective of the total number of carbon atoms in the carotenoid molecule (49) . Thus, the product distribution of the CrtM variants can be discerned from the HPLC chromatogram peak heights (at 286 nm) for each product. As can be seen in 
Analysis of mutations
The most significant and only recurring mutations found in the 10 sequenced CrtM variants were those at F26. In seven variants, phenylalanine is replaced by leucine, while two have serine at this position. The F26L substitution alone is sufficient for acquisition of C 40 activity by CrtM (M 8 ; Table 2 Thus, it is apparent that mutation at this residue is not the only means by which CrtM can acquire CrtB-like activity. Of all 10 sequenced variants, M 10 is the only one with no substitution for phenylalanine at position 26 and is also the only one whose cultures did not have decreased C 30 pathway performance compared to CrtM cultures.
Structural considerations: mapping mutations onto human squalene synthase
Most structurally characterized isoprenoid biosynthetic enzymes, including FPS, squalene synthase (SqS), and terpene cyclases, have the same "isoprenoid synthase fold," consisting predominantly of α-helices (22) . In addition, secondary structure prediction (11) and sequence alignment (8) of CrtM and CrtB with their related enzymes also suggest that the enzymes have a common fold. Given this, and the lack of a crystal structure for a carotenoid synthase, we mapped the amino acid substitutions in our CrtM variants onto the crystal structure of human SqS (37).
SqSs catalyze the first committed step in cholesterol biosynthesis. As with carotene synthases, this is the head-to-head condensation of two identical prenyl diphosphates (FPP for SqS). The condensation reaction catalyzed by SqS proceeds in two distinct steps (38) . The first half-reaction generates the stable intermediate presqualene diphosphate, which forms upon abstraction of a diphosphate group from a prenyl donor, followed by 1-1' condensation of the donor and acceptor molecules. In the second halfreaction, the intermediate undergoes a complex rearrangement followed by a second removal of diphosphate and a final carbocation-quenching process (Figure 2.7) . SqSs catalyze the additional reduction of the central double bond of 4,4'-diapophytoene (also called dehydrosqualene) by NADPH to form squalene, a reaction not performed by carotene synthases. Because the SqS and carotene synthase enzymes share clusters of conserved amino acids and catalyze essentially identical reactions, it is probable that they also have the same reaction mechanism. Indeed, when NADPH is in short supply, SqS produces 4,4'-diapophytoene, the natural product of CrtM (19, 52) .
Sequence alignment of CrtM with related enzymes implies that F26 in CrtM corresponds to I58 in human SqS, which is located in helix B and points into the pocket that accommodates the second half-reaction. This residue is located four amino acids downstream of a flexible "flap" region in SqS that is believed to form a "lid" that shields intermediates in the reaction pocket from water (37) . The amino acids constituting the flap are almost completely conserved among all known head-to-head isoprenoid synthase enzymes that catalyze 1-1' condensation.
It is noteworthy that a single mutation at F26 of CrtM is sufficient to permit this enzyme to synthesize C 40 carotenoids. Because this position is thought to lie in the site of the second half-reaction (rearrangement and quenching of a cyclopropylcarbinyl intermediate) (37) , and because wild-type CrtM produces trace amounts of phytoene (indicating that initially accepting two molecules of GGPP is not impossible), it is likely that wild-type CrtM is able to perform the first half-reaction of phytoene synthesis (condensation of two molecules of GGPP to form a presqualene diphosphate-like structure). We hypothesize that the F26 residue prevents the second half-reaction from going to completion by acting as a steric or electrostatic inhibitor of intermediate rearrangement. When this bulky phenylalanine residue is replaced with a smaller or more flexible amino acid such as serine or leucine, the second half-reaction is permitted to proceed and phytoene is produced.
Similar results for a variety of short-chain isoprenyl diphosphate synthases (IDSs) have been reported. In this class of enzymes, the size of the fifth amino acid upstream of the first aspartate-rich motif determines product length (29, 32, 33, 35, 36) . Based on a very strong correlation between average product length and surface area of amino acids in this position (36) , as well as the available crystal structure for avian FPS (47) , it was hypothesized that this residue forms a steric barrier or wall that controls the size of the products (30) . This model has been successfully applied to a variety of other enzymes in this family, including medium-chain IDSs (53) . It is unknown why so many IDSs differing so greatly in sequence share a single key residue that determines product specificity.
Evolution of phytoene synthase (CrtB) in a C 30 pathway
We constructed mutant libraries of crtB to search for variants with C 30 activity. Upon transformation into XL1-Blue, pUC-crtB-crtN, containing wild-type crtB, gave no discernible pigmentation, while the pUC-crtM-crtN cells produced had intense yellow pigmentation. Among the ~43,000 colonies expressing pUC-[crtB]-crtN variants screened, not a single one showed distinguishable yellow (or other) pigmentation. Thus, we found no CrtB mutants with improved C 30 activity. We also constructed five additional pUC-[crtB]-crtN libraries by using the Genemorph PCR mutagenesis kit (Stratagene), which enables the construction of randomly mutagenized gene libraries with a mutational spectrum different from that of those generated by mutagenic PCR with MnCl 2 (7) . We screened an additional ~10,000 variants, but again found no variants of CrtB able to synthesize C 30 carotenoids at appreciable levels.
An explanation for the relative difficulty in acquiring C 30 function for CrtB may be that accepting a smaller-than-natural substrate is a more difficult task for this type of enzyme than accepting a larger-than-natural substrate. However, an evolutionary explanation may also be in order. The contexts in which the two enzymes evolved differ markedly. FPP is a precursor for many life-supporting compounds and is present in all organisms. Thus, C 40 enzymes such as CrtB have evolved in the presence of FPP throughout their history. It is not unreasonable to infer that CrtB has evolved under a nontrivial selection pressure to minimize consumption of FPP, for accepting FPP as a substrate and bypassing GGPP could be detrimental to the host organism's fitness. In stark contrast, C 30 synthases have evolved in an environment essentially devoid of GGPP.
Consequently, no pressure to reject this substrate has been placed on these enzymes.
CONCLUSIONS
We have demonstrated for the first time that the specificity of a carotenoid synthase is easily and profoundly altered by directed evolution. In our experiments, the carotene synthases CrtM and CrtB failed to complement one another in their respective foreign pathways. However, upon random mutagenesis of crtM followed by C 40 carotenoid backbone. However, the enzyme is very poor at condensing two molecules of GGPP to form the C 40 carotenoid backbone, phytoene. By broadening the specificity of CrtM through point mutagenesis, we have created variants that can also synthesize C 40 carotenoids. That these mutants can synthesize two non-native products as a result of the addition of only one new precursor (GGPP) to their substrate repertoires is a consequence of both their broadened specificity as well as the nature of the coupling reaction catalyzed by carotenoid synthases. If a (mutant) carotenoid synthase does not discriminate between n different prenyl diphosphate substrates, it will synthesize n(n+1)/2 different carotenoid backbones by virtue of the combinatorics of substrate coupling. Therefore, carotenoid synthases, by virtue of their special chemistry, can act as key "diversity-multiplying" enzymes in carotenoid biosynthetic pathways if suitable mutants able to accept nonnative precursors can be found. In the following chapter, we describe the continuation of our efforts to further expand carotenoid biosynthesis by creating additional backbones that can serve as new branch points for carotenoid pathway diversification.
MATERIALS AND METHODS
Materials
Erwinia uredovora (current approved name: Pantoea ananatis) C 40 carotenoid pathway genes crtE encoding GGPP (C 20 PP) synthase, crtB encoding phytoene synthase, and crtI encoding phytoene desaturase were obtained by genomic PCR as previously described (43) . The Escherichia coli farnesyl diphosphate (FPP, C 15 PP) synthase gene fps was cloned from E. coli strain JM109. The C 30 pathway genes crtM (4,4'-diapophytoene synthase) and crtN (4,4'-diapophytoene desaturase) were cloned by PCR from Staphylococcus aureus genomic DNA (ATCC no. 35556D). We used E. coli XL1-Blue supercompetent cells (Stratagene, La Jolla, CA) for cloning, screening, and carotenoid biosynthesis. AmpliTaq polymerase (Perkin-Elmer, Boston, MA) was employed for mutagenic PCR, while Vent polymerase (New England Biolabs, Beverly, MA) was used for cloning PCR. All chemicals and reagents used were of the highest available grade.
Plasmid construction
Plasmid maps and sequences can be found in Appendix A. 
Pigment analysis
Among the strains we tested as expression hosts, XL1-Blue showed the best results in terms of stability and intensity of the color developed by colonies on agar plates.
Although all of the genes assembled in each plasmid are grouped under a single lac operator/promoter, our expression system showed no response in terms of pigmentation levels to different IPTG (isopropyl-β-D-thiogalactopyranoside) concentrations. Thus, leaky transcription from the lac promoter was sufficient for carotenoid production in E.
coli. Based on this observation, all experiments described in this report were performed without IPTG induction.
To measure the relative amounts of carotenoids synthesized (see CrtM, or a mutant CrtM) were cultivated in 50 ml of TB+carbenicillin (50 mg/l) for 40 h at 160 rpm and 28 °C in 250-ml tissue culture flasks. The OD 600 of each culture was measured immediately before harvesting, and the dry cell mass was determined from this measurement by using a calibration curve generated for similar cultures. After centrifugation, the cell pellets were extracted with 10 ml of an acetone-methanol mixture determined by comparing their HPLC chromatogram peak heights (at 286 nm) to a calibration curve generated using known amounts of a β,β-carotene standard (Sigma), and then multiplying by ε β,β-carotene (450 nm) /ε phytoene (286 nm) . The values of the molar extinction coefficients (ε) used in the calculation were 138,900 and 49,800, respectively (6) . The molar quantities of carotenoids were then normalized to the dry cell mass of each culture. 
